版本:
中国

BRIEF-Blueprint Medicines enrolls first patient in BLU-667 Phase 1 clinical trial

March 20 Blueprint Medicines Corp

* Blueprint Medicines announces enrollment of first patient in Phase 1 clinical trial for BLU-667 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐